Company: UHS
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0000950170-25-027785
Chunk: 341

Company: UNIVERSAL HEALTH SERVICES INC
Filing Date: 2025-02-26
Form: 10-K
Item: Item 7
Chunk 341
---
 with: (i) open market purchases pursuant to our stock repurchase program ($599 million), and; (ii) income tax withholding obligations related to stock-based compensation programs ($72 million);

•spent $53 million to pay quarterly cash dividends of $.20 per share; 

•generated $15 million from the issuance of shares of our Class B Common Stock pursuant to the terms of employee stock purchase plans;

•received $13 million from the sale of ownership interests to minority members;

•spent $13 million to pay financing costs, and;

•spent $7 million to pay profit distributions related to noncontrolling interests in majority owned businesses.

2023:

The $494 million of net cash used in financing activities during 2023 consisted of the following:

•generated $185 million of proceeds from additional borrowings pursuant to our revolving credit facility;

•spent $547 million to repurchase shares of our Class B Common Stock in connection with: (i) open market purchases pursuant to our stock repurchase program ($524 million), and; (ii) income tax withholding obligations related to stock-based compensation programs ($23 million);

•spent $85 million on net repayment of debt as follows: (i) $79 million related to our tranche A term loan facility, and; (ii) $6 million related to other debt facilities; 

69

•spent $55 million to pay quarterly cash dividends of $.20 per share; 

•generated $14 million from the issuance of shares of our Class B Common Stock pursuant to the terms of employee stock purchase plans;

•spent $7 million to pay profit distributions related to noncontrolling interests in majority owned businesses, and;

•received $3 million for the purchase of minority ownership interests in majority owned businesses.    

2025 Expected Capital Expenditures:

During 2025, we expect to spend approximately $850 million to $1.000 billion on capital expenditures which includes expenditures for capital equipment, construction of new facilities, and renovations and expansions at existing hospitals. We believe that our capital expenditure program is adequate to expand, improve and equip our existing hospitals. We expect to finance all capital expenditures and acquisitions with internally generated funds and/or additional funds, as discussed below.

Capital Resources:

Credit Facilities and Outstanding Debt Securities

In September, 2024, we completed the following financing transactions:

•The public offering of $500 million of aggregate principal amount of 4.625% senior secured notes due on October 15, 2029 ("2029 Notes");

•The public offering of $500 million of